Our Team
Our team includes world-leading experts in molecular biology, medicinal chemistry and artificial intelligence from several research institutions including the Harvard University, Stanford University, National University of Singapore, Karolinska Institute, and University College London, and with ample industry experiences from Johnson & Johnson, BeiGene, and AstraZeneca. Our team members bring extensive industry experience from companies such as Johnson & Johnson, BeiGene, and AstraZeneca, ensuring a seamless integration of scientific excellence with industry innovation.
Ling Wu, PhD
-
Dr. Wu Ling is a seasoned cancer immunologist with over a decade of experience in therapeutics. He was formerly a group leader at BeiGene and serves as an advisor to the International Society of Pharmaceutical Engineering (ISPE). He holds a PhD from the National University of Singapore and is a recipient of the Outstanding Research Award.
Jie Sun
-
Sun Jie is an AI specialist with deep experience in health data science and AI-driven drug development. She held data science roles at Dana-Farber and Mass General, with research published in The Lancet and AAAI. Previously, she cofounded Basys.ai, a healthtech startup backed by the Mayo Clinic and Eli Lilly. A 40 Under 40 honoree by the Boston Congress of Public Health, she mentors startups at MIT, NUS, and MassChallenge, and writes on AI and entrepreneurship for Forbes. She holds an MS in Health Data Science from Harvard and a BS in Statistics from NUS.
Prof. Nicholas Gascoigne
-
Prof. Nicholas is a world-renowned immunologist and Fellow of the Royal Society of Biology. A pioneer in T cell biology, he co-discovered the TCR gene with Mark Davis and has over 30 years of research experience. Former President of the Singapore Immunology Society, his work has been cited over 10,000 times, including publications in Nature and Science.
https://medicine.nus.edu.sg/mbio/about-us/our-people/academic-staff/nicholas-gascoigne.html
Hancheng Zhang, PhD
-
Dr Zhang is a seasoned medicinal chemist with 15+ years at Johnson & Johnson leading small-molecule drug design, followed by roles as SVP of Chemistry at ChemPartner (managing 300+ scientists) and founder of Innogate Pharma. He is also the former president of the Sino-America Pharmaceutical Professionals Association.
